University of Kentucky receives $11.3 million COBRE Phase 2 award
The University of Kentucky has received an $11.3 million NIH Centers of Biomedical Research Excellence (COBRE) Phase 2 award from the National Institute of General Medical Sciences. The five-year grant will support continued development of the Center for Translational Chemical Biology and its efforts to advance research at the intersection of chemical biology and pharmaceutical science.